speb/financial-data huggingface dataset:
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 14007030000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 392950000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 1096710000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1489660000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 6528380000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 414560000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 92470000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 29080960000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 757490000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 34433620000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 518160000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 3473030000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 1922050000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 5395080000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 660920000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 11680000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 21090000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 29080960000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 31322390000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 601380000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 251870000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 268547382.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 232900000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 1081540000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 30877770000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 92470000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 183790000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 384200000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 24552180000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 7188880000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Payables: 2181980000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 268547382.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 31414860000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 31322390000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 45100810000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 33336910000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 6884740000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 31426540000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 13674270000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 31093480000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 7145890000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 111430000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 7478650000.00
MEDANTA.NS income_statement (quarterly, 2024-09-30) — Write Off: 60920000.00
MEDANTA.NS income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
MEDANTA.NS income_statement (quarterly, 2024-12-31) — Write Off: 34110000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — +Operating Expense: 21292110000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 5421940000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — +Total Revenue: 36923450000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 9312520000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1948120000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1948120000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2918560000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2918560000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -10501340000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -10501340000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 10720340000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 10720340000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -416490000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -416490000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Amortization: 18350000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 18350000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 182110000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 182110000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 268659040.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 268965517.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Basic EPS: 17.92
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 3.77
MEDANTA.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 4246080000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 12332370000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 12332370000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -6479150000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 3898490000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 3898490000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 537170000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 537170000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 2302000000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2302000000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 10507210000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 10507210000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 1481740000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 1481740000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 820260000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 820260000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -2910000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -126890000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -188770000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Change In Payable: 125880000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -949070000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -997050000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -1944080000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Common Stock: 537170000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 537170000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 33864100000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 33864100000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 12660000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Common Stock Payments: 0.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 5285210000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 5285210000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 8796690000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2136190000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Current Assets: 15331230000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 15331230000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 304430000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 304430000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Current Debt: 637830000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 637830000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 942260000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 942260000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 6188170000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 6188170000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 228670000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 228670000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Depreciation: 1937480000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 1937480000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 1937480000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 492540000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 1937480000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 492540000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 268659040.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 268965517.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Diluted EPS: 17.92
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 3.77
MEDANTA.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 4814370000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1014000000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — EBIT: 7125160000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — EBIT: 1484680000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — EBITDA: 9062640000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — EBITDA: 1977220000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — End Cash Position: 2302000000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -972260000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -241560000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -2190000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 4973430000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1315920000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 112850000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 112850000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 3335050000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 3335050000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 40861930000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 40861930000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Gross Profit: 28126760000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 7176330000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Interest Expense: 652590000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 150300000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 652590000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 150300000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Interest Income: 703180000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 703180000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -536800000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 671740000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Inventory: 671410000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 671410000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 37142930000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 37142930000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -7209410000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 182110000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 182110000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 12660000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 1491650000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 6427660000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 6427660000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 3594060000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 3594060000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 2641000000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 2641000000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 6235060000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 6235060000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 1491650000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -1834270000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 661680000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 661680000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 1688350000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1688350000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 10970000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 10970000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Minority Interests: 1190000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 220000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 12660000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Net Debt: 976830000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 976830000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -3700000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Net Income: 4814370000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Net Income: 1014000000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 4814370000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1014000000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 4813180000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1013780000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 4814370000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1014000000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 4814370000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1014000000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 6472570000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 4813180000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1013780000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -1313700000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Net Interest Income: -652590000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -150300000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -1431940000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -342620000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -342620000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -652590000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -150300000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -105500000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -1387080000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Net PPE: 30360590000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 30360590000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -5135510000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 33751250000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 33751250000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 221160000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 221160000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 330230000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 330230000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 661680000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 661680000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 634510000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 634510000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 9561600000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 2476180000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Normalized Income: 5185410296.64
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 1393079174.45
MEDANTA.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 6237590000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Operating Income: 6834650000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Operating Income: 1754390000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Operating Revenue: 36923450000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 9312520000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 268587382.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 268587382.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 189930000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 189930000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 609150000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 609150000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 2520000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 2520000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 112850000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 112850000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 240950000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 512640000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 512640000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 221160000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 221160000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 789470000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 229250000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 6135780000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1572940000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Other Payable: 1551850000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 1551850000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Other Properties: 15128340000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 15128340000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 310050000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 310050000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 8205210000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 8205210000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Other Special Charges: 496500000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Payables: 3499970000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Payables: 3499970000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 245310000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 245310000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 207860000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 207860000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Pretax Income: 6472570000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 1334380000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 39640000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -1313700000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -1431940000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -5165450000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 671410000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 671410000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 8796690000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2136190000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 1937480000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 492540000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 712380000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 712380000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -1834270000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: 0.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Research And Development: 4140000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 716140000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 716140000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Restructuring And Mergern Acquisition: 498960000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 498960000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 22484800000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 22484800000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 29940000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 298210000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 4973430000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1315920000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Share Issued: 268587382.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 268587382.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Special Income Charges: -498960000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: -498960000.00
MEDANTA.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 0.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 33864100000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 33864100000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 33751250000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 33751250000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -127919703.36
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -119880825.55
MEDANTA.NS income_statement (annual, 2025-03-31) — Tax Provision: 1659390000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 320600000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.26
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
MEDANTA.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -1642360000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Total Assets: 47662300000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 47662300000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 36505100000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 36505100000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Total Debt: 7177320000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 7177320000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 33875070000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 33875070000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Total Expenses: 30088800000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 7558130000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 13787230000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 13787230000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 32331070000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 32331070000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 7599060000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 7599060000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 103250000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -498960000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -498960000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -498960000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -498960000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 477080000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 477080000.00
MEDANTA.NS balance_sheet (annual, 2025-03-31) — Working Capital: 9143060000.00
MEDANTA.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 9143060000.00
MEDANTA.NS income_statement (annual, 2025-03-31) — Write Off: 447170000.00
MEDANTA.NS income_statement (quarterly, 2025-03-31) — Write Off: 303110000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 6099030000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 10308370000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 268596284.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 5.92
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2390570000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 451080000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 451080000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 269050761.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 5.91
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1590090000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — EBIT: 2219260000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — EBITDA: 2670340000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1367000000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 7917800000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 137850000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 137850000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 271000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Net Income: 1590090000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1590090000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1589820000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1590090000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1590090000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1589820000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -137850000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -137850000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 2474420000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 1440442629.04
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Operating Income: 1818770000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 10308370000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 204570000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1716910000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Other Special Charges: -195920000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 2081410000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2390570000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 451080000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1367000000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 195920000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 46272629.04
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 491590000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 8489600000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 195920000.00
MEDANTA.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 195920000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 6624510000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 10992220000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2507490000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3650970000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 313280000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 269000000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 5.89
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 4181620000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 537580000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 7591840000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 12546400000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 537580000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 37076530000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 3175170000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2555560000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 17285810000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 243060000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 720390000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 963450000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 7206530000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 317230000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 497260000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 497260000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 269000000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 5.89
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1584410000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — EBIT: 2169260000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — EBITDA: 2666520000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1549450000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 157910000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 35011020000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 8436660000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 171120000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 171120000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 732580000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 42343840000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 313280000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 3938560000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 4546920000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 8485480000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 734370000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 25300000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Minority Interests: -410000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Net Income: 1584410000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1584410000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1584000000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1584410000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 1584410000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1584000000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -171120000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -171120000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 35011020000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 36918620000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 198720000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 2506670000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 1457690951.28
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Operating Income: 1812150000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 10992220000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 268637432.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 355860000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1534050000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 36538950000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 157910000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 396560000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 563130000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 197260000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1834460000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 31835850000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 4954560000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Payables: 2507490000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 1998140000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2555560000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 497260000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: -159850000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1549450000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 268790382.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 159850000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 37076530000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 36918620000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 33130951.28
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 414140000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 54095460000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 41623450000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 9448930000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 37101830000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 9180070000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 16993630000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 36809650000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 9787100000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 159850000.00
MEDANTA.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 159850000.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 152950.00
MEDANTA.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 10079280000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 7092800000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 11210470000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 268423729.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 3.54
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2556590000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 611880000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 611880000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 268423729.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 3.54
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 950220000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — EBIT: 1412920000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — EBITDA: 2024800000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1793950000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 8653880000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 215090000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 215090000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -110000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Net Income: 950220000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 950220000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 950330000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 950220000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 950220000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 950330000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -215090000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -215090000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 2390780000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 1240579878.61
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Operating Income: 1561080000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 11210470000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 217820000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1880240000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Other Special Charges: 365980000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 1197830000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2556590000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 611880000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1793950000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -365980000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -75620121.39
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 247500000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 9649390000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -365980000.00
MEDANTA.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -365980000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — +Operating Expense: 27169070000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 7352730000.00
MEDANTA.NS income_statement (annual, 2026-03-31) — +Total Revenue: 44102660000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 11590470000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 2423700000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2423700000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 4111850000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 4111850000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 1142380000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 1142380000.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 268634328.00
MEDANTA.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 5.36
MEDANTA.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 2302000000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -9785870000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 5589710000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 5589710000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 537380000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 537380000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1273330000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1273330000.00
MEDANTA.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 11623870000.00
MEDANTA.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 11623870000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -134400000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -118420000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -98040000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 137820000.00
MEDANTA.NS cash_flow (annual, 2026-03-31) — Change In Payable: 535680000.00